The impact of hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies

Hepatitis Monthly

Volumn 11, Issue 4, 2011, Pages 247-254

  Rostami, Zohreh ^a   Nourbala, Mohammad Hossien ^a   Alavian, Seyed Moayed ^a   Bieraghdar, Fatemeh ^a   Jahani, Yunes ^a   Einollahi, Behzad ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Graft survival; Hepatitis C infection; Kidney transplantation; Mortality; Natural history; Outcome assessment; Patient survival

Indexed keywords

CAUSE OF DEATH; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORTALITY; OBSERVATIONAL STUDY; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84857847993     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Luan FL, Schaubel DE, Zhang H, Jia X, Pelletier SJ, Port FK, et al. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Transplantation. 2008;85(11):1601-1606.
2. Romero E, Galindo P, Bravo JA, Osorio JM, Perez A, Baca Y, et al. Hepatitis C virus infection after renal transplantation. Transplant Proc. 2008;40(9):2933-2935.
3. Lezaic V, Stosovic M, Marinkovic J, Rangelov V, Djukanovic L. Hepatitis B and hepatitis C virus infection and outcome of hemodi-alysis and kidney transplant patients. Ren Fail. 2008;30(1):81-87.
4. Einollahi B, Alavian SM. Hepatitis C virus infection and kidney transplantation: a review for clinicians. Iran J Kidney Dis. 2010;4(1):1-8.
5. Alavian SM. Patient survival after renal transplantation in HCV and HBV infected patients needs more attention than other risk factors. Clin Nephrol. 2009;72(4):326-327.
6. Dominguez-Gil B, Morales JM. Transplantation in the patient with hepatitis C. Transpl Int. 2009;22(12):1117-1131.
7. Toz H, Nart D, Turan I, Ersoz G, Sezis M, Asci G, et al. The acquisition time of infection: a determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients. Clin Transplant. 2009;23(5):723-731.
8. Fabrizi F, Lunghi G, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther. 2006;24(10):1413-1422.
9. Savas N, Ocal S, Colak T, Karakayali H, Yilmaz U, Haberal M. Clinical course of hepatitis C virus infection in renal transplant recipients. Transplant Proc. 2007;39(4):984-986.
10. Fabrizi F, Bromberg J, Elli A, Dixit V, Martin P. Review article: hepatitis C virus and calcineurin inhibition after renal transplantation. Aliment Pharmacol Ther. 2005;22(8):657-666.
11. Einollahi B, Hajarizadeh B, Bakhtiari S, Lesanpezeshki M, Khatami MR, Nourbala MH, et al. Pretransplant hepatitis C virus infection and its efect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol. 2003;18(7):836-840.
12. Aroldi A, Lampertico P, Montagnino G, Passerini P, Villa M, Camp-ise MR, et al. Natural history of hepatitis B and C in renal al-lograft recipients. Transplantation. 2005;79(9):1132-1136.
13. Legendre C, Garrigue V, Le Bihan C, Mamzer-Bruneel MF, Chaix ML, Landais P, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation. 1998;65(5):667-670.
14. Gentil MA, Rocha JL, Rodriguez-Algarra G, Pereira P, Lopez R, Bernal G, et al. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant. 1999;14(10):2455-2460.
15. Lee WC, Shu KH, Cheng CH, Wu MJ, Chen CH, Lian JC. Long-term impact of hepatitis B, C virus infection on renal transplantation. Am J Nephrol. 2001;21(4):300-306.
16. Breitenfeldt MK, Rasenack J, Berthold H, Olschewski M, Schrof J, Strey C, et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant. 2002;16(2):130-136.
17. Bruchfeld A, Wilczek H, Elinder CG. Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation. Transplantation. 2004;78(5):745-750.
18. Morales JM. Hepatitis C virus infection and renal disease after renal transplantation. Transplant Proc. 2004;36(3):760-762.
19. Ingsathit A, Thakkinstian A, Kantachuvesiri S, Sumethkul V. Diferent impacts of hepatitis B virus and hepatitis C virus on the outcome of kidney transplantation. Transplant Proc. 2007;39(5):1424-1428.
20. Batty DS, Jr., Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant. 2001;1(2):179-184.
21. Mahmoud IM, Elhabashi AF, Elsawy E, El-Husseini AA, Sheha GE, Sobh MA. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis. 2004;43(1):131-139.
22. Lin HH, Huang CC, Huang JY, Yang CW, Wu MS, Fang JT, et al. Impact of HCV infection on frst cadaveric renal transplantation, a single center experience. Clin Transplant. 2004;18(3):261-266.
23. Ridruejo E, Cusumano A, Diaz C, Davalos Michel M, Jost L, Josth L, et al. Hepatitis C virus infection and outcome of renal transplantation. Transplant Proc. 2007;39(10):3127-3130.
24. Gentil Govantes MA, Rodriguez-Benot A, Sola E, Osuna A, Mazue-cos A, Bedoya R, et al. Trends in kidney transplantation outcome: the Andalusian Kidney Transplant Registry, 1984-2007. Transplant Proc. 2009;41(5):1583-1585.
25. Mitwalli AH, Alam A, Al-Wakeel J, Al Suwaida K, Tarif N, Schaar TA, et al. Efect of chronic viral hepatitis on graft survival in Saudi renal transplant patients. Nephron Clin Pract. 2006;102(2):c72-c80.
26. Periera BJ, Wright TL, Schmid CH, Levey AS. The impact of pre-transplantation hepatitis C infection on the outcome of renal transplantation. Transplantation. 1995;60(8):799-805.
27. Pereira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, et al. Efects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int. 1998;53(5):1374-1381.
28. Gentil MA, Perez-Valdivia MA, Munoz-Terol JM, Borrego J, Mazu-ecos A, Osuna A, et al. Are we still making progress in patient survival after kidney transplantation? Results of a regional registry. Transplant Proc. 2009;41(6):2085-2088.
29. Hernandez D, Sanchez-Fructuoso A, Gonzalez-Posada JM, Arias M, Campistol JM, Rufno M, et al. A novel risk score for mortality in renal transplant recipients beyond the frst posttransplant year. Transplantation. 2009;88(6):803-809.